OTC Archives -

Futura Medical’s development of a topical treatment for erectile dysfunction (ED) is approaching the finish line in the

Futura eyes FDA filing as topical ED drug passes phase 3 test

https://pharmaphorum.com/news/futura-eyes-fda-filing-as-topical-ed-drug-passes-phase-3-test/

Market Access/ News/ News/ News/ Patients

HRA Pharma bids to bring first OTC contraceptive pill to US

Phil Taylor contraception, HRA Pharma, OTC, Perrigo, regulatory, women's health 0 Comment

Perrigo’s HRA Pharma subsidiary has become the first drugmaker in the US to seek approval for an over-the-counter

HRA Pharma bids to bring first OTC contraceptive pill to US

https://pharmaphorum.com/news/hra-pharma-bids-to-bring-first-otc-contraceptive-pill-to-us/

News/ News/ Sales and Marketing

Sanofi’s plans for OTC Cialis hit a snag in US

Phil Taylor cialis, Eli Lilly, erectile dysfunction, OTC, Pfizer, Sanofi, Viagra 0 Comment

It has been eight years since Sanofi licensed rights to an over-the-counter version of erectile dysfunction (ED) drug

Sanofi’s plans for OTC Cialis hit a snag in US

https://pharmaphorum.com/news/sanofis-plans-for-otc-cialis-hit-a-snag-in-us/

News

Takeda to sell European OTC business to cut debts

Richard Staines M&A, Orifarm, OTC, Takeda 0 Comment

Japan’s Takeda has said it would sell up to $670 million of over-the-counter (OTC) drug operations in Europe

Takeda to sell European OTC business to cut debts

https://pharmaphorum.com/news/takeda-to-sell-european-otc-business-to-cut-debts/

stada_headquarter_building_bad_vilbel_06

News

Stada expands OTC business with portfolio of GSK drugs

Richard Staines allergy, dermatology, GlaxoSmithKline, M&A, OTC, Stada 0 Comment

Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products

Stada expands OTC business with portfolio of GSK drugs

https://pharmaphorum.com/news/stada-expands-otc-business-with-portfolio-of-gsk-drugs/

News/ News/ Sales and Marketing

Takeda nets $660m from product selloff to Germany’s Stada

Phil Taylor emerging markets, generic, OTC, Russia, Stada, Takeda 0 Comment

Takeda has divested another block of products it views as lying outside its main focus, selling various drugs

Takeda nets $660m from product selloff to Germany’s Stada

https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/

News

GSK/Pfizer form consumer health joint venture

Richard Staines consumer health, GlaxoSmithKline, OTC, Pfizer 0 Comment

GlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer

GSK/Pfizer form consumer health joint venture

https://pharmaphorum.com/news/gsk-pfizer-form-consumer-health-joint-venture/

M&A/ News

P&G buys Merck KGaA’s consumer health unit for $4.2bn

Richard Staines M&A, Merck KGaA, OTC 0 Comment

Merck KGaA is to sell its consumer health business to Procter and Gamble for $4.2 billion, continuing the

P&G buys Merck KGaA’s consumer health unit for $4.2bn

https://pharmaphorum.com/news/pg-buys-merck-kgaas-consumer-health-unit-4-2bn/

GlaxoSmithKline/ M&A/ News

GSK to pay $13bn for Novartis stake in OTC joint venture

Richard Staines GlaxoSmithKline, M&A, Novartis, OTC 0 Comment

GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to

GSK to pay $13bn for Novartis stake in OTC joint venture

https://pharmaphorum.com/news/gsk-wants-take-control-otc-joint-venture/

Trending

OTC

Login